Showing results (311-320 of 355) with videos related to
Sort By:
Pageof 36
British Journal of Clinical Pharmacology|May 20, 2016
Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicityFolefac Aminkeng, Colin J D Ross, Shahrad R Rassekh, et al.HIV Medicine|December 22, 2020
Increased case-finding and uptake of direct-acting antiviral treatment essential for micro-elimination of hepatitis C among people living with HIV: a national record linkage studyA McLeod, S J Hutchinson, S Smith, et al.Circulation|December 7, 2021
Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced CardiotoxicityTarek Magdy, Mariam Jouni, Hui-Hsuan Kuo, et al.Journal of Viral Hepatitis|April 11, 2014
Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action PlanS A McDonald, S J Hutchinson, H A Innes, et al.Journal of Viral Hepatitis|August 12, 2016
A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapyE J Aspinall, W Mitchell, J Schofield, et al.The Pharmacogenomics Journal|January 19, 2011
Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatinL R Brunham, P J Lansberg, L Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2018
Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer PatientsBritt I Drögemöller, Beth Brooks, Carol Critchley, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2023
Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I TrialEtan Orgel, Kristin R Knight, Yueh-Yun Chi, et al.The Pharmacogenomics Journal|April 17, 2013
Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descentF Aminkeng, C J D Ross, S R Rassekh, et al.Archives of Women'S Mental Health|July 7, 2021
A cross-sectional study of the relationship between CYP2D6 and CYP2C19 variations and depression symptoms, for women taking SSRIs during pregnancyCatriona Hippman, Caitlin Slomp, Emily Morris, et al.Pageof 36